Yüklüyor......
Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial
IMPORTANCE: Buprenorphine treatment for opioid use disorder may be improved by sustained-release formulations. OBJECTIVE: To determine whether treatment involving novel weekly and monthly subcutaneous (SC) buprenorphine depot formulations is noninferior to a daily sublingual (SL) combination of bupr...
Kaydedildi:
| Yayımlandı: | JAMA Intern Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Medical Association
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6145749/ https://ncbi.nlm.nih.gov/pubmed/29799968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2018.1052 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|